Biomimetic gold nanocomplexes for gene knockdown: Will gold deliver dividends for small interfering RNA nanomedicines?

Kanasty, R.; Dorkin, J. R.; Vegas, A.; Anderson, D. Delivery materials for siRNA therapeutics. Nat. Mater. 2013, 12, 967–977.

Guo, J.; Bourre, L.; Soden, D. M.; O'Sullivan, G. C.; O'Driscoll, C. Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics? Biotechnol. Adv. 2011, 29, 402–417.

Mohseni, M.; Sun, J.; Lau, A.; Curtis, S.; Goldsmith, J.; Fox, V. L.; Wei, C.; Frazier, M.; Samson, O.; Wong, K. K.; Kim, C.; Camargo, F. D. A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway. Nat. Cell Biol. 2014, 16, 108–117.

Schramek, D.; Sendoel, A.; Segal, J. P.; Beronja, S.; Heller, E.; Oristian, D.; Reva, B.; Fuchs, E. Direct in vivo RNAi screen unveils myosin Ⅱa as a tumor suppressor of squamous cell carcinomas. Science 2014, 343, 309–313.

Guo, J. F.; Cahill, M. R.; McKenna, S. L.; O'Driscoll, C. M. Biomimetic nanoparticles for siRNA delivery in the treatment of leukaemia. Biotechnol. Adv. 2014, 32, 1396–1409.

Strumberg, D.; Schultheis, B.; Traugott, U.; Vank, C.; Santel, A.; Keil, O.; Giese, K.; Kaufmann, J.; Drevs, J. Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors. Int. J. Clin. Pharmacol. Ther. 2012, 50, 76–78.

Tabernero, J.; Shapiro, G. I.; LoRusso, P. M.; Cervantes, A.; Schwartz, G. K.; Weiss, G. J.; Paz-Ares, L.; Cho, D. C.; Infante, J. R.; Alsina, M. et al. First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement. Cancer Discov. 2013, 3, 406–417.

Williford, J. M.; Wu, J.; Ren, Y.; Archang, M. M.; Leong, K. W.; Mao, H. Q. Recent advances in nanoparticle-mediated siRNA delivery. Annu. Rev. Biomed. Eng. 2014, 16, 347–370.

Giacca, M.; Zacchigna, S. Virus-mediated gene delivery for human gene therapy. J. Control. Release 2012, 161, 377–388.

Waehler, R.; Russell, S. J.; Curiel, D. T. Engineering targeted viral vectors for gene therapy. Nat. Rev. Genet. 2007, 8, 573–587.

Ginn, S. L.; Alexander, I. E.; Edelstein, M. L.; Abedi, M. R.; Wixon, J. Gene therapy clinical trials worldwide to 2012-an update. J. Gene. Med. 2013, 15, 65–77.

Cobley, C. M.; Chen, J.; Cho, E. C.; Wang, L. V.; Xia, Y. Gold nanostructures: A class of multifunctional materials for biomedical applications. Chem. Soc. Rev. 2011, 40, 44–56.

Wen, S.; Li, K.; Cai, H.; Chen, Q.; Shen, M.; Huang, Y.; Peng, C.; Hou, W.; Zhu, M.; Zhang, G. et al. Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications. Biomaterials 2013, 34, 1570–1580.

Barhate, G.; Gautam, M.; Gairola, S.; Jadhav, S.; Pokharkar, V. Quillaja saponaria extract as mucosal adjuvant with chitosan functionalized gold nanoparticles for mucosal vaccine delivery: Stability and immunoefficiency studies. Int. J. Pharm. 2013, 441, 636–642.

Okuno, T.; Kato, S.; Hatakeyama, Y.; Okajima, J.; Maruyama, S.; Sakamoto, M.; Mori, S.; Kodama, T. Photothermal therapy of tumors in lymph nodes using gold nanorods and near-infrared laser light. J. Control. Release 2013, 172, 879–884.

Jing, L.; Liang, X.; Deng, Z.; Feng, S.; Li, X.; Huang, M.; Li, C.; Dai, Z. Prussian blue coated gold nanoparticles for simultaneous photoacoustic/CT bimodal imaging and photothermal ablation of cancer. Biomaterials 2014, 35, 5814–5821.

Huang, P.; Pandoli, O.; Wang, X. S.; Wang, Z.; Li, Z. M.; Zhang, C. L.; Chen, F.; Lin, J.; Cui, D. X.; Chen, X. Y. Chiral guanosine 5'-monophosphate-capped gold nanoflowers: Controllable synthesis, characterization, surface-enhanced Raman scattering activity, cellular imaging and photothermal therapy. Nano Res. 2012, 5, 630–639.

Kim, D. W.; Kim, J. H.; Park, M.; Yeom, J. H.; Go, H.; Kim, S.; Han, M. S.; Lee, K.; Bae, J. Modulation of biological processes in the nucleus by delivery of DNA oligonucleotides conjugated with gold nanoparticles. Biomaterials 2011, 32, 2593–2604.

Bao, Q. Y.; Geng, D. D.; Xue, J. W.; Zhou, G.; Gu, S. Y.; Ding, Y.; Zhang, C. Glutathione-mediated drug release from Tiopronin-conjugated gold nanoparticles for acute liver injury therapy. Int. J. Pharm. 2013, 446, 112–118.

Ding, Y.; Zhou, Y. Y.; Chen, H.; Geng, D. D.; Wu, D. Y.; Hong, J.; Shen, W. B.; Hang, T. J.; Zhang, C. The performance of thiol-terminated PEG-paclitaxel-conjugated gold nanoparticles. Biomaterials 2013, 34, 10217–10227.

Monem, A. S.; Elbialy, N.; Mohamed, N. Mesoporous silica coated gold nanorods loaded doxorubicin for combined chemo-photothermal therapy. Int. J. Pharm. 2014, 470, 1–7.

Bao, C.; Conde, J.; Polo, E.; del Pino, P.; Moros, M.; Baptista, P. V.; Grazu, V.; Cui, D.; de la Fuente, J. M. A promising road with challenges: Where are gold nanoparticles in translational research? Nanomedicine (Lond) 2014, 9, 2353–2570.

Daniel, M. C.; Astruc, D. Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 2004, 104, 293–346.

Link, S.; EI-Sayed, M. A. Size and temperature dependence of the plasmon absorption of colloidal gold nanoparticles. J. Phys. Chem. B 1999, 103, 4212–4217.

Sperling, R. A.; Rivera Gil, P.; Zhang, F.; Zanella, M.; Parak, W. J. Biological applications of gold nanoparticles. Chem. Soc. Rev. 2008, 37, 1896–1908.

Huang, X.; Jain, P. K.; El-Sayed, I. H.; El-Sayed, M. A. Gold nanoparticles: Interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond) 2007, 2, 681–693.

Dreaden, E. C.; Alkilany, A. M.; Huang, X.; Murphy, C. J.; El-Sayed, M. A. The golden age: Gold nanoparticles for biomedicine. Chem. Soc. Rev. 2012, 41, 2740–2779.

Murphy, C. J.; Sau, T. K.; Gole, A. M.; Orendorff, C. J.; Gao, J.; Gou, L.; Hunyadi, S. E.; Li, T. Anisotropic metal nanoparticles: Synthesis, assembly, and optical applications. J. Phys. Chem. B 2005, 109, 13857–13870.

Orendorff, C. J.; Sau, T. K.; Murphy, C. J. Shape-dependent plasmon-resonant gold nanoparticles. Small 2006, 2, 636–639.

Rahme, K.; Gauffre, F.; Marty, J. D.; Payre, B.; Mingotaud, C. A systematic study of the stabilization in water of gold nanoparticles by poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers. J. Phys. Chem. C 2007, 111, 7273–7279.

Kelly, K. L.; Coronado, E.; Zhao, L. L.; Schatz, G. C. The optical properties of metal nanoparticles: The influence of size, shape, and dielectric environment. J. Phys. Chem. B 2003, 107, 668–677.

Niu, J.; Zhu, T.; Liu, Z. One-step seed-mediated growth of 30–150 nm quasispherical gold nanoparticles with 2-mercaptosuccinic acid as a new reducing agent. Nanotechnology 2007, 18, 325607.

Perrault, S. D.; Chan, W. C. Synthesis and surface modification of highly monodispersed, spherical gold nanoparticles of 50–200 nm. J. Am. Chem. Soc. 2009, 131, 17042–17043.

Huang, Y.; Kim, D. H. Synthesis and self-assembly of highly monodispersed quasispherical gold nanoparticles. Langmuir 2011, 27, 13861–13867.

Rahme, K.; Chen, L.; Hobbs, R. G.; Morris, M. A.; O'Driscoll, C.; Holmes, J. D. PEGylated gold nanoparticles: Polymer quantification as a function of PEG lengths and nanoparticle dimensions. RSC Adv. 2013, 3, 6085–6094.

Cai, W.; Gao, T.; Hong, H.; Sun, J. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol. Sci. Appl. 2008, 2008, 17–32.

Li, C. Y.; Fan, F. R.; Yin, B. S.; Chen, L.; Ganguly, T.; Tian, Z. Q. Au⁺-cetyltrimethylammonium bromide solution: A novel precursor for seed-mediated growth of gold nanoparticles in aqueous solution. Nano Res. 2013, 6, 29–37.

Abdelhalim, M. A. K.; Mady, M. M.; Ghannam, M. M. Physical properties of different gold nanoparticles: Ultraviolet-visible and fluorescence measurements. J. Nanomed. Nanotechnol. 2012, 3, 1000133.

Eustis, S.; EI-Sayed, M. A. Why gold nanoparticles are more precious than pretty gold: Noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes. Chem. Soc. Rev. 2006, 35, 209–217.

Hohenau, A.; Krenn, J. R.; Schider, G.; Ditlbacher, H.; Leitner, A.; Aussenegg, F. R.; Schaich, W. L. Optical near-field of multipolar plasmons of rod-shaped gold nanoparticles. Europhys. Lett. 2005, 69, 538–543.

Link, S.; EI-Sayed, M. A. Spectral properties and relaxation dynamics of surface plasmon electronic oscillations in gold and silver nanodots and nanorods. J. Phys. Chem. B 1999, 103, 8410–8426.

Sau, T. K.; Murphy, C. J. Room temperature, high-yield synthesis of multiple shapes of gold nanoparticles in aqueous solution. J. Am. Chem. Soc. 2004, 126, 8648–8649.

Hao, E.; Bailey, R. C.; Schatz, G. C.; Hupp, J. T.; Li, S. Synthesis and optical properties of "branched" gold nanocrystals. Nano Lett. 2004, 4, 327–330.

Murphy, C. J.; Gole, A. M.; Hunyadi, S. E.; Orendorff, C. J. One-dimensional colloidal gold and silver nanostructures. Inorg. Chem. 2006, 45, 7544–7554.

Perez-Juste, J.; Pastoriza-Santos, I.; Liz-Marzan, L. M.; Mulvaney, P. Gold nanorods: Synthesis, characterization and applications. Coordin. Chem. Rev. 2005, 249, 1870–1901.

Jiang, X. C.; Brioude, A.; Pileni, M. P. Gold nanorods: Limitations on their synthesis and optical properties. Colloid Surf. A-Physicochem. Eng. Asp. 2006, 277, 201-2–06.

Link, S.; Mohamed, M. B.; EI-Sayed, M. A. Simulation of the optical absorption spectra of gold nanorods as a function of their aspect ratio and the effect of the medium dielectric constant. J. Phys. Chem. B 1999, 103, 3073–3077.

Liang, Z.; Li, X.; Xie, Y.; Liu, S. 'Smart'gold nanoshells for combined cancer chemotherapy and hyperthermia. Biomed. Mater. 2014, 9, 025012.

Xia, Y.; Li, W.; Cobley, C. M.; Chen, J.; Xia, X.; Zhang, Q.; Yang, M.; Cho, E. C.; Brown, P. K. Gold nanocages: From synthesis to theranostic applications. Acc. Chem. Res. 2011, 44, 914–924.

Dreaden, E. C.; Mackey, M. A.; Huang, X.; Kang, B.; EI-Sayed, M. A. Beating cancer in multiple ways using nanogold. Chem. Soc. Rev. 2011, 40, 3391–3404.

Terentyuk, G.; Panfilova, E.; Khanadeev, V.; Chumakov, D.; Genina, E.; Bashkatov, A.; Tuchin, V.; Bucharskaya, A.; Maslyakova, G.; Khlebtsov, N. et al. Gold nanorods with a hematoporphyrin-loaded silica shell for dual-modality photodynamic and photothermal treatment of tumors in vivo. Nano Res. 2014, 7, 325–337.

Goettmann, F.; Moores, A.; Boissiere, C.; Le Floch, P.; Sanchez, C. A selective chemical sensor based on the plasmonic response of phosphinine‐stabilized gold nanoparticles hosted on periodically organized mesoporous silica thin layers. Small 2005, 1, 636–639.

Liz-Marzan, L. M.; Giersig, M.; Mulvaney, P. Synthesis of nanosized gold-silica core-shell particles. Langmuir 1996, 12, 4329–4335.

Underwood, S.; Mulvaney, P. Effect of the solution refractive index on the color of gold colloids. Langmuir 1994, 10, 3427–3430.

Ung, T.; Liz-Marzan, L. M.; Mulvaney, P. Optical properties of thin films of Au@SiO₂ particles. J. Phys. Chem. B 2001, 105, 3441–3452.

Maye, M. M.; Lim, I. I.; Luo, J.; Rab, Z.; Rabinovich, D.; Liu, T.; Zhong, C. J. Mediator-template assembly of nanoparticles. J. Am. Chem. Soc. 2005, 127, 1519–1529.

Kumar, A.; Zhang, X.; Liang, X. J. Gold nanoparticles: Emerging paradigm for targeted drug delivery system. Biotechnol. Adv. 2013, 31, 593–606.

Rana, S.; Bajaj, A.; Mout, R.; Rotello, V. M. Monolayer coated gold nanoparticles for delivery applications. Adv. Drug Deliv. Rev. 2012, 64, 200–216.

Kumar, D.; Saini, N.; Jain, N.; Sareen, R.; Pandit, V. Gold nanoparticles: An era in bionanotechnology. Expert Opin. Drug Deliv. 2013, 10, 397–409.

Frens, G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature Phy. Sci. 1973, 241, 20–22.

Turkevich, J.; Stevenson, P. C.; Hillier, J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss. Faraday Soc. 1951, 11, 55–75.

Dumur, F.; Guerlin, A.; Dumas, E.; Bertin, D.; Gigmes, D.; Mayer, C. R. Controlled spontaneous generation of gold nanoparticles assisted by dual reducing and capping agents. Gold Bull. 2011, 44, 119–137.

Katti, K.; Chanda, N.; Shukla, R.; Zambre, A.; Suibramanian, T.; Kulkarni, R. R.; Kannan, R.; Katti, K. V. Green nanotechnology from cumin phytochemicals: Generation of biocompatible gold nanoparticles. Int. J. Green Nanotechol. Biomed. 2009, 1, B39–B52.

Ganeshkumar, M.; Ponrasu, T.; Raja, M. D.; Subamekala, M. K.; Suguna, L. Green synthesis of pullulan stabilized gold nanoparticles for cancer targeted drug delivery. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2014, 130, 64–71.

Iram. Y.; Igbal, M. S.; Athar, M. M.; Saeed, M. Z.; Yasmeen, A.; Ahmad, R. Glucoxylan-mediated green synthesis of gold and silver nanoparticles and their phyto-toxicity study. Carbohydr. Polym. 2014, 104, 29–33.

Menon, D.; Basanth, A.; Retnakumari, A.; Manzoor, K.; Nair, S. V. Green synthesis of biocompatible gold nanocrystals with tunable surface plasmon resonance using garlic phytochemicals. J. Biomed. Nanotechnol. 2012, 8, 901–911.

Mohan Kumar, K.; Mandal, B. K.; Kiran Kumar, H. A.; Maddinedi, S. B. Green synthesis of size controllable gold nanoparticles. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2013, 116, 539–545.

Correa-Llanten, D. N.; Muñoz-Ibacache, S. A.; Castro, M. E.; Munoz, P. A.; Blamey, J. M. Gold nanoparticles synthesized by geobacillus sp strain ID17 a thermophilic bacterium isolated from deception island, antarctica. Microb. Cell Fact. 2013, 12, 75.

Mittal, A. K.; Chisti, Y.; Banerjee, U. C. Synthesis of metallic nanoparticles using plant extracts. Biotechnol. Adv. 2013, 31, 346–356.

Rahme, K.; Nolan, M. T.; Doody, T.; McGlacken, G. P.; Morris, M. A.; O'Driscoll, C.; Holmes, J. D. Highly stable PEGylated gold nanoparticles in water: Applications in biology and catalysis. RSC Adv. 2013, 3, 21016–21024.

Guo, J.; Armstrong, M. J.; O'Driscoll, C. M.; Holmes, J. D.; Rahme, K. Positively charged, surfactant-free gold nanoparticles for nucleic acid delivery. RSC Adv. 2015, 5, 17862–17871.

Brust, M.; Walker, M.; Bethell, D.; Schiffrin, D. J.; Whyman, R. Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system. J. Chem. Soc., Chem. Commun. 1994, 801–802.

Sardar, R.; Funston, A. M.; Mulvaney, P.; Murray, R. W. Gold nanoparticles: Past, present, and future. Langmuir 2009, 25, 13840–13851.

Lu, W.; Huang, Q.; Ku, G.; Wen, X.; Zhou, M.; Guzatov, D.; Brecht, P.; Su, R.; Oraevsky, A.; Wang, L.V. et al. Photoacoustic imaging of living mouse brain vasculature using hollow gold nanospheres. Biomaterials 2010, 31, 2617–2626.

Kim, D.; Jeong, Y. Y.; Jon, S. A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano 2010, 4, 3689–3696.

Jain, N. K.; Nahar, M. PEGylated nanocarriers for systemic delivery. In Cancer Nanotechnology: Methods and Protocols; Grobmyer, S. R.; Moudgil, B. M., Eds.; Springer: New York, 2010; pp 221–234.

Amoozgar, Z.; Yeo, Y. Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2012, 4, 219–233.

Santos-Martinez, M. J.; Rahme, K.; Corbalan, J. J.; Faulkner, C.; Holmes, J. D.; Tajber, L.; Medina, C.; Radomski, M. W. Pegylation increases platelet biocompatibility of gold nanoparticles. J. Biomed. Nanotechnol. 2014, 10, 1004–1015.

Pooja, D.; Panyaram, S.; Kulhari, H.; Rachamalla, S. S.; Sistla, R. Xanthan gum stabilized gold nanoparticles: Characterization, biocompatibility, stability and cytotoxicity. Carbohydr. Polym. 2014, 110, 1–9.

Latorre, A.; Posch, C.; Garcimartín, Y.; Celli, A.; Sanlorenzo, M.; Vujic, I.; Ma, J.; Zekhtser, M.; Rappersberger, K.; Ortiz-Urda, S. et al. DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics. Nanoscale 2014, 6, 7436–7442.

Imperatore, R.; Carotenuto, G.; Di Grazia, M. A.; Ferrandino, I.; Palomba, L.; Mariotti, R.; Vitale, E.; De Nicola, S.; Longo, A.; Cristino, L. Imidazole-stabilized gold nanoparticles induce neuronal apoptosis: An in vitro and in vivo study. J. Biomed. Mater. Res. A 2015, 103, 1436–1446.

Hinterwirth, H.; Lindner, W.; Lammerhofer, M. Bioconjugation of trypsin onto gold nanoparticles: Effect of surface chemistry on bioactivity. Anal. Chim. Acta 2012, 733, 90–97.

Tao, W.; Ziemer, K. S.; Gill, H. S. Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus. Nanomedicine (Lond) 2014, 9, 237–251.

Ling, D.; Hackett, M. J.; Hyeon, T. Surface ligands in synthesis, modification, assembly and biomedical applications of nanoparticles. Nano Today 2014, 9, 457–477.

Zhang, Z.; Jia, J.; Lai, Y.; Ma, Y.; Weng, J.; Sun, L. Conjugating folic acid to gold nanoparticles through glutathione for targeting and detecting cancer cells. Bioorg. Med. Chem. 2010, 18, 5528–5534.

Choi, C. H.; Alabi, C. A.; Webster, P.; Davis, M. E. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc. Natl. Acad. Sci. USA 2010, 107, 1235–1240.

Prades, R.; Guerrero, S.; Araya, E.; Molina, C.; Salas, E.; Zurita, E.; Selva, J.; Egea, G.; Lopez-Iglesias, C.; Teixido, M. et al. Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor. Biomaterials 2012, 33, 7194–7205.

Chang, Y. C.; Yang, C. Y.; Sun, R. L.; Cheng, Y. F.; Kao, W. C.; Yang, P. C. Rapid single cell detection of staphylococcus aureus by aptamer-conjugated gold nanoparticles. Sci. Rep. 2013, 3, 1863.

Kumar, S.; Aaron, J.; Sokolov, K. Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties. Nat. Protoc. 2008, 3, 314–420.

Shiao, Y. S.; Chiu, H. H.; Wu, P. H.; Huang, Y. F. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery. ACS Appl. Matyer. Interfaces 2014, 6, 21832–21841.

Arosio, D.; Chiodo, F.; Reina, J. J.; Marelli, M.; Penades, S.; van Kooyk, Y.; Garcia-Vallejo, J. J.; Bernardi, A. Effective targeting of DC-SIGN by α-fucosylamide functionalized gold nanoparticles. Bioconjug. Chem. 2014, 25, 2244–2251.

Choi, H. S.; Liu, W.; Liu, F.; Nasr, K.; Misra, P.; Bawendi, M. G.; Frangioni, J. V. Design considerations for tumour-targeted nanoparticles. Nat. Nanotechnol. 2010, 5, 42–47.

Rosi, N. L.; Giljohann, D. A.; Thaxton, C. S.; Lytton-Jean, A. K.; Han, M. S.; Mirkin, C. A. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 2006, 312, 1027–1030.

Conde, J.; Larguinho, M.; Cordeiro, A.; Raposo, L. R.; Costa, P. M.; Santos, S.; Diniz, M. S.; Fernandes, A. R.; Baptista, P. V. Gold-nanobeacons for gene therapy: Evaluation of genotoxicity, cell toxicity and proteome profiling analysis. Nanotoxicology 2014, 8, 521–532.

Kim, J. H.; Yeom, J. H.; Ko, J. J.; Han, M. S.; Lee, K.; Na, S. Y.; Bae, J. Effective delivery of anti-miRNA DNA oligonucleotides by functionalized gold nanoparticles. J. Biotechnol. 2011, 155, 287–292.

Crew, E.; Tessel, M. A.; Rahman, S.; Razzak-Jaffar, A.; Mott, D.; Kamundi, M.; Yu, G.; Tchah, N.; Lee, J.; Bellavia, M. et al. MicroRNA conjugated gold nanoparticles and cell transfection. Anal. Chem. 2012, 84, 26–29.

Hao, L.; Patel, P. C.; Alhasan, A. H.; Giljohann, D. A.; Mirkin, C. A. Nucleic acid-gold nanoparticle conjugates as mimics of microRNA. Small 2011, 7, 3158–3162.

Conde, J.; Rosa, J.; de la Fuente, J. M.; Baptisata, P. V. Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events. Biomaterials 2013, 34, 2516–2523.

Kong, W. H.; Bae, K. H.; Hong, C. A.; Lee, Y.; Hahn, S. K.; Park, T. G. Multimerized siRNA cross-linked by gold nanoparticles. Bioconjug. Chem. 2011, 22, 1962–1969.

Giljohann, D. A.; Seferos, D. S.; Prigodich, A. E.; Patel, P. C.; Mirkin, C. A. Gene regulation with polyvalent siRNA-nanoparticle conjugates. J. Am. Chem. Soc. 2009, 131, 2072–2073.

Lee, J. S.; Green, J. J.; Love, K. T.; Sunshine, J.; Langer, R.; Anderson, D. G. Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett. 2009, 9, 2402–2406.

Patel, P. C.; Hao, L.; Yeung, W. S.; Mirkin, C. A. Duplex end breathing determines serum stability and intracellular potency of siRNA-Au NPs. Mol. Pharm. 2011, 8, 1285–1291.

Son, S.; Nam, J.; Kim, J.; Kim, S.; Kim, W. J. i-motif-driven Au nanomachines in programmed siRNA delivery for gene-silencing and photothermal ablation. ACS Nano 2014, 8, 5574–5584.

Jensen, S. A.; Day, E. S.; Ko, C. H.; Hurley, L. A.; Luciano, J. P.; Kouri, F. M.; Merkel, T. J.; Luthi, A. J.; Patel, P. C.; Cutler, J. I. et al. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma. Sci. Transl. Med. 2013, 5, 209ra152.

Zheng, D.; Giljohann, D. A.; Chen, D. L.; Massich, M. D.; Wang, X. Q.; Iordanov, H.; Mirkin, C. A.; Paller, A. S. Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc. Natl. Acad. Sci. USA 2012, 109, 11975–11980.

Conde, J.; Tian, F.; Hernandez, Y.; Bao, C.; Cui, D.; Janssen, K. P.; Ibarra, M. R. Baptista, P. V.; Stoeger, T.; de la Fuente, J. M. In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models. Biomaterials 2013, 34, 7744–7753.

Lu, W.; Zhang, G.; Zhang, R.; Flores, L. G. 2^nd; Huang, Q.; Gelovani, J. G.; Li, C. Tumor site-specific silencing of NF-κB p65 by targeted hollow gold nanosphere-mediated photothermal transfection. Cancer Res. 2010, 70, 3177–3188.

Ghosh, R.; Singh, L. C.; Shohet, J. M.; Gunaratne, P. H. A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells. Biomaterials 2013, 34, 807–816.

Song, W. J.; Du, J. Z.; Sun, T. M.; Zhang, P. Z.; Wang, J. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. Small 2010, 6, 239–246.

Huang, S.; Deshmukh, H.; Rajagopalan, K. K.; Wang, S. Gold nanoparticles electroporation enhanced polyplex delivery to mammalian cells. Electrophoresis 2014, 35, 1837–1845.

Lee, Y.; Lee, S. H.; Kim, J. S.; Maruyama, A.; Chen, X.; Park, T. G. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery. J. Control. Release 2011, 155, 3–10.

Kong, W. H.; Bae, K. H.; Jo, S. D.; Kim, J. S.; Park, T. G. Cationic lipid-coated gold nanoparticles as efficient and non-cytotoxic intracellular siRNA delivery vehicles. Pharm. Res. 2012, 29, 362–374.

Lee, S. H.; Bae, K. H.; Kim, S. H.; Lee, K. R.; Park, T. G. Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers. Int. J. Pharm. 2008, 364, 94–101.

Kim, S. T.; Chompoosor, A.; Yeh, Y. C.; Agasti, S. S.; Solfiell, D. J.; Rotello, V. M. Dendronized gold nanoparticles for siRNA delivery. Small 2012, 8, 3253–3256.

Mitra, M.; Kandalam, M.; Rangasamy, J.; Shankar, B.; Maheswari, U. K.; Swaminathan, S.; Krishnakumar, S. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells. Mol. Vis. 2013, 19, 1029–1038.

Zhao, E.; Zhao, Z.; Wang, J.; Yang, C.; Chen, C.; Gao, L.; Feng, Q.; Hou, W.; Gao, M.; Zhang, Q. Surface engineering of gold nanoparticles for in vitro siRNA delivery. Nanoscale 2012, 4, 5102–5109.

Guo, S.; Huang, Y.; Jiang, Q.; Sun, Y.; Deng, L.; Liang, Z.; Du, Q.; Xing, J.; Zhao, Y.; Wang, P. C. Enhanced gene delivery and siRNA silencing by gold nanoparticles coated with charge-reversal polyelectrolyte. ACS Nano 2010, 4, 5505–5511.

Lee, S. K.; Han, M. S.; Asokan, S.; Tung, C. H. Effective gene silencing by multilayered siRNA-coated gold nanoparticles. Small 2011, 7, 364–370.

Han, L.; Zhao, J.; Zhang, X.; Cao, W.; Hu, X.; Zou, G.; Duan, X.; Liang, X. J. Enhanced siRNA delivery and silencing gold–chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility. ACS Nano 2012, 6, 7340–7351.

Elbakry, A.; Zaky, A.; Liebl, R.; Rachel, R.; Goepferich, A.; Breunig, M. Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett. 2009, 9, 2059–2064.

Bonoiu, A. C.; Mahajan, S. D.; Ding, H.; Roy, I.; Yong, K. T.; Kumar, R.; Hu, R.; Bergey, E. J.; Schwartz, S. A.; Prasad, P. N. Nanotechnology approach for drug addiction therapy: Gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons. Proc. Natl. Acad. Sci. USA 2009, 106, 5546–5550.

Bonoiu, A. C.; Bergey, E. J.; Ding, H.; Hu, R.; Kumar, R.; Yong, K. T.; Prasad, P. N.; Mahajan, S.; Picchione, K. E.; Bhattacharjee, A. et al. Gold nanorod-siRNA induces efficient in vivo gene silencing in the rat hippocampus. Nanomedicine (Lond) 2011, 6, 617–630.

Lee, M. Y.; Park, S. J.; Park, K.; Kim, K. S.; Lee, H.; Hahn, S. K. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. ACS Nano 2011, 5, 6138–6147.

Bishop, C. J.; Tzeng, S. Y.; Green, J. J. Degradable polymer-coated gold nanoparticles for co-delivery of DNA and siRNA. Acta Biomater. 2015, 11, 393–403.

Yan, Y.; Bjornmalm, M.; Caruso, F. Assembly of layer-by-layer particles and their interactions with biological systems. Chem. Mater. 2014, 26, 452–460.

Mintzer, M. A.; Simanek, E. E. Nonviral vectors for gene delivery. Chem. Rev. 2009, 109, 259–302.

Zhang, Y.; Wang, Z.; Gemeinhart, R. A. Progress in microRNA delivery. J. Control. Release 2013, 172, 962–974.

Guo, J.; Evans, J. C.; O'Driscoll, C. M. Delivering RNAi therapeutics with non-viral technology: A promising strategy for prostate cancer? Trends Mol. Med. 2013, 19, 250–261.

Wilson, R. C.; Doudna, J. A. Molecular mechanisms of RNA interference. Annu. Rev. Biophys. 2013, 42, 217–239.

Fellmann, C.; Lowe, S. W. Stable RNA interference rules for silencing. Nat. Cell Biol. 2014, 16, 10–18.

Guo, J.; Fisher, K. A.; Darcy, R.; Cryan, J. F.; O'Driscoll, C. Therapeutic targeting in the silent era: Advances in non-viral siRNA delivery. Mol. Biosyst. 2010, 6, 1143–1161.

Chan, E.; Prado, D. E.; Weidhaas, J. B. Cancer microRNAs: From subtype profiling to predictors of response to therapy. Trends Mol. Med. 2011, 17, 235–243.

Leal, J. A.; Feliciano, A.; Lleonart, M. E. Stem cell microRNAs in senescence and immortalization: Novel players in cancer therapy. Med. Res. Rev. 2013, 33, 112–138.

Momi, N.; Kaur, S.; Rachagani, S.; Ganti, A. K.; Batra, S. K. Smoking and microRNA dysregulation: A cancerous combination. Trends Mol. Med. 2014, 20, 36–47.

Haasnoot, J.; Westerhout, E. M.; Berkhout, B. RNA interference against viruses: Strike and counterstrike. Nat. Biotechnol. 2007, 25, 1435–1443.

Lu, P. Y.; Xie, F. Y.; Woodle, M. C. Modulation of angiogenesis with siRNA inhibitors for novel therapeutics. Trends Mol. Med. 2005, 11, 104–113.

Fitzgerald, K. A.; Evans, J. C.; McCarthy, J.; Guo, J.; Prenciple, M.; Kearney, M.; Watson, W. R.; O'Driscoll C. M. The role of transcription factors in prostate cancer and potential for future RNA interference therapy. Expert Opin. Ther. Thargets 2014, 18, 633–649.

Bennink, J. R.; Palmore, T. N. The promise of siRNAs for the treatment of influenza. Trends Mol. Med. 2004, 10, 571–574.

Whitehead, K. A.; Langer, R.; Anderson, D. G. Knocking down barriers: Advances in siRNA delivery. Nat. Rev. Drug Discov. 2009, 8, 129–138.

Cole, L. E.; Vargo-Gogola, T.; Roeder, R. K. Contrast-enhanced X-ray detection of breast microcalcifications in a murine model using targeted gold nanoparticles. ACS Nano 2014, 8, 7486–7496.

Chong, R. H.; Gonzalez-Gonzalez, E.; Lara, M. F.; Speaker, T. J.; Contag, C. H.; Kaspar, R. L.; Coulman, S. A.; Hargest, R.; Birchall, J. C. Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept. J. Control. Release 2013, 166, 211–219.

Burgess, A.; Hynynen, K. Noninvasive and targeted drug delivery to the brain using focused ultrasound. ACS Chem. Neurosci. 2013, 4, 519–526.

Wang, Y. H.; Chen, S. P.; Liao, A. H.; Yang, Y. C.; Lee, C. R; Wu, C. H.; Wu, P. C.; Liu, T. M.; Wang, C. R.; Li, P. C. Synergistic delivery of gold nanorods using multifunctional microbubbles for enhanced plasmonic photothermal therapy. Sci. Rep. 2014, 4, 5685.

Wegscheid, M. L.; Morshed, R. A.; Cheng, Y.; Lesniak, M. S. The art of attraction: Applications of multifunctional magnetic nanomaterials for malignant glioma. Expert Opin. Drug Deliv. 2014, 11, 957–975.

Hyodo, M.; Sakurai, Y.; Akita, H.; Harashima, H. "Programmed packaging" for gene delivery. J. Control. Release 2014, 193, 316–323.

Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Bombelli, F. B.; Dawson, K. A. Physical-chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133, 2525–2534.

Salvati, A.; Pitek, A. S.; Monopoli, M. P.; Prapainop, K.; Bombelli, F. B.; Hristov, D. R.; Kelly, P. M.; Aberg, C.; Mahon, E.; Dawson, K. A. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 2013, 8, 137–143.

de Wolf, H. K.; Snel, C. J.; Verbaan, F. J.; Schiffelers, R. M.; Hennink, W. E.; Storm, G. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration. Int. J. Pharm. 2007, 331, 167–175.

Cao-Milan, R.; Liz-Marzan, L. M. Gold nanoparticle conjugates: Recent advances toward clinical applications. Expert Opin. Drug Deliv. 2014, 11, 741–752.

Iosin, M.; Toderas, F.; Baldeck, P. L.; Astilean, S. Study of protein-gold nanoparticle conjugates by fluorescence and surface-enhanced Raman scattering. J. Mol. Struct. 2009, 924–926, 196–200.

Pan, B.; Cui, D.; Xu, P.; Li, Q.; Huang, T.; He, R.; Gao, F. Study on interaction between gold nanorod and bovine serum albumin. Colloid Surf. A-Physicochem. Eng. Asp. 2007, 295, 217–222.

Brewer, S. H.; Glomm, W. R.; Johnson, M. C.; Knag, M. K.; Franzen, S. Probing BSA binding to citrate-coated gold nanoparticles and surfaces. Langmuir 2005, 21, 9303–9307.

Alkilany, A. M.; Thompson, L. B.; Boulos, S. P.; Sisco, P. N.; Murphy, C. J. Gold nanorods: Their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions. Adv. Drug Deliv. Rev. 2012, 64, 190–199.

Jokerst, J. V.; Lobovkina, T.; Zare, R. N.; Gambhir, S. S. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond) 2011, 6, 715–728.

Guo, J.; Ogier, J. R.; Desgranges, S.; Darcy, R.; O'Driscoll, C. Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice. Biomaterials 2012, 33, 7775–7784.

Gao, J.; Chen, H.; Yu, Y.; Song, J.; Song, H.; Su, X.; Li, W.; Tong, X.; Qian, W.; Wang, H. et al. Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA. Biomaterials 2013, 34, 10084–10098.

Leus, N. G.; Morselt, H. W.; Zwiers, P. J.; Kowalski, P. S.; Ruiters, M. H.; Molema, G.; Kamps, J. A. VCAM-1 specific PEGylated SAINT-based lipoplexes deliver siRNA to activated endothelium in vivo but do not attenuate target gene expression. Int. J. Pharm. 2014, 469, 121–131.

Koide, H.; Asai, T.; Hatanaka, K.; Akai, S.; Ishii, T.; Kenjo, E.; Ishida, T.; Kiwada, H.; Tsukada, H.; Oku, N. T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes. Int. J. Pharm. 2010, 392, 218–223.

Schellekens, H.; Hennink, W. E.; Brinks, V. The immunogenicity of polyethylene glycol: Facts and fiction. Pharm. Res. 2013, 30, 1729–1734.

He, Z.; Liu, J.; Du, L. The unexpected effect of PEGylated gold nanoparticles on the primary function of erythrocytes. Nanoscale 2014, 6, 9017–9024.

Moghimi, S. M.; Hunter, A. C.; Andresen, T. L. Factors controlling nanoparticle pharmacokinetics: An integrated analysis and perspective. Annu. Rev. Pharmacol. Toxicol. 2012, 52, 481–503.

Quail, D. F.; Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 2013, 19, 1423–1437.

Chithrani, B. D.; Ghazani, A. A.; Chan, W. C. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006, 6, 662–668.

Suresh, D.; Zambre, A.; Chanda, N.; Hoffman, T. J.; Smith, C. J.; Robertson, J. D.; Kannan, R. Bombesin peptide conjugated gold nanocages internalize via clathrin mediated endocytosis. Bioconjug. Chem. 2014, 25, 1565–1579.

Junttila, M. R.; de Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013, 501, 346–354.

Egeblad, M.; Nakasone, E. S.; Werb, Z. Tumors as organs: Complex tissues that interface with the entire organism. Dev. Cell 2010, 18, 884–901.

Ruan, S.; Yuan, M.; Zhang, L.; Hu, G.; Chen, J.; Cun, X.; Zhang, Q.; Yang, Y.; He, Q.; Gao H. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles. Biomaterials 2015, 37, 425–435.

O'Mahony, A. M.; Godinho, B. M.; Cryan, J. F.; O'Driscoll, C. M. Non-viral nanosystems for gene and small interfering RNA delivery to the central nervous system: Formulating the solution. J. Pharm. Sci. 2013, 102, 3469–3484.

Chen, Y.; Liu, L. Modern methods for delivery of drugs across the blood-brain barrier. Adv. Drug Deliv Rev. 2012, 64, 640–665.

Huang, R.; Ke, W.; Liu, Y.; Jiang, C.; Pei, Y. The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain. Biomaterials 2008, 29, 238–246.

Kumar, P.; Wu, H.; McBride, J. L.; Jung, K. E.; Kim, M. H.; Davidson, B. L.; Lee, S. K.; Shankar, P.; Manjunath, N. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007, 448, 39–43.

Chacko, A. M.; Li, C.; Pryma, D. A.; Brem, S.; Coukos, G.; Muzykantov, V. Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: Crossing the blood-brain barrier divide. Expert Opin. Drug Deliv. 2013, 10, 907–926.

Allen, T. M. Ligand-targeted therapeutics in anticancer therapy. Nat. Rev. Cancer 2002, 2, 750–763.

Wang, F.; Shen, Y.; Zhang, W.; Li, M.; Wang, Y.; Zhou, D.; Guo, S. Efficient, dual-stimuli responsive cytosolic gene delivery using a RGD modified disulfide-linked polyethylenimine functionalized gold nanorod. J. Control. Release 2014, 196, 37–51.

Sakurai, Y.; Hatakeyama, H.; Sato, Y.; Akita, H.; Takayama, K.; Kobayashi, S.; Futaki, S.; Harashima, H. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA. Biomaterials 2011, 32, 5733–5742.

Guo, J.; Cheng, W. P.; Gu, J.; Ding, C.; Qu, X.; Yang, Z.; O'Driscoll, C. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice. Eur. J. Pharm. Sci. 2012, 45, 521–532.

Kwon, Y. J. Before and after endosomal escape: Roles of stimuli-converting siRNA/polymer interactions in determining gene silencing efficiency. Acc. Chem. Res. 2012, 45, 1077–1088.

Koren, E.; Torchilin, V. P. Cell-penetrating peptides: Breaking through to the other side. Trends Mol. Med. 2012, 18, 385–393.

Knight, M. W.; Sobhani, H.; Nordlander, P.; Halas, N. J. Photodetection with active optical antennas. Science 2011, 332, 702–704.

Schmidt, B.; Loeschner, K.; Hadrup, N.; Mortensen, A.; Sloth, J. J.; Koch, C. B.; Larsen, E. H. Quantitative characterization of gold nanoparticles by field-flow fractionation coupled online with light scattering detection and inductively coupled plasma mass spectrometry. Anal. Chem. 2011, 83, 2461–2468.

Fratoddi, I.; Venditti, I.; Cametti, C.; Russo, M. V. How toxic are gold nanoparticles? The State-of-the-Art. Nano Res. 2015, 8, 1771–1799.

Xue, H. Y.; Liu, S.; Wong, H. L. Nanotoxicity: A key obstacle to clinical translation of siRNA-based nanomedicine. Nanomedicine (Lond) 2014, 9, 295–312.

Zhang, X. D.; Wu, D.; Shen, X.; Liu, P. X.; Yang, N.; Zhao, B.; Zhang, H.; Sun, Y. M.; Zhang, L. A.; Fan, F. Y. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int. J. Nanomedicine 2011, 6, 2071–2081.

Sun, Y. N.; Wang, C. D.; Zhang, X. M.; Ren, L.; Tian, X. H. Shape dependence of gold nanoparticles on in vivo acute toxicological effects and biodistribution. J. Nanosci. Nanotechnol. 2011, 11, 1210–1216.

Thakor, A. S.; Luong, R.; Paulmurugan, R.; Lin, F. I.; Kempen, P.; Zavaleta, C.; Chu, P.; Massoud, T. F.; Sinclair, R.; Gambhir, S. S. The fate and toxicity of Raman-active silica-gold nanoparticles in mice. Sci. Transl. Med. 2011, 3, 79ra33.

Simpson, C. A.; Salleng, K. J.; Cliffel, D. E.; Feldheim, D. L. In vivo toxicity, biodistribution, and clearance of glutathione-coated gold nanoparticles. Nanomedicine 2013, 9, 257–263.

Zhang, X. D.; Wu, H. Y.; Wu, D.; Wang, Y. Y.; Chang, J. H.; Zhai, Z. B.; Meng, A. M. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int. J. Nanomedicine 2010, 5, 771–781.

Abdelhalim, M. A.; Jarrar, B. M. Gold nanoparticles induced cloudy swelling to hydropic degeneration, cytoplasmic hyaline vacuolation, polymorphism, binucleation, karyopyknosis, karyolysis, karyorrhexis and necrosis in the liver. Lipids Health Dis. 2011, 10, 166.

Chen, H.; Dorrigan, A.; Saad, S.; Hare, D. J.; Cortie, M. B.; Valenzuela, S. M. In vivo study of spherical gold nanoparticles: Inflammatory effects and distribution in mice. PLoS One 2013, 8, e58208.

You, J.; Zhou, J.; Zhou, M.; Liu, Y.; Robertson, J. D.; Liang, D.; Van Pelt, C.; Li, C. Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres. Part. Fibre. Toxicol. 2014, 11, 26.

Abdelhalim, M. A.; Jarrar, B. M. The appearance of renal cells cytoplasmic degeneration and nuclear destruction might be an indication of GNPs toxicity. Lipids Health Dis. 2011, 10, 147.

Liu, X.; Huang, N.; Wang, H.; Li, H.; Jin, Q.; Ji, J. The effect of ligand composition on the in vivo fate of multidentate poly(ethylene glycol) modified gold nanoparticles. Biomaterials 2013, 34, 8370–8381.

Chen, J.; Wang, H.; Long, W.; Shen, X.; Wu, D.; Song, S. S.; Sun, Y. M.; Liu, P. X.; Fan, S.; Fan, F. et al. Sex differences in the toxicity of polyethylene glycol-coated gold nanoparticles in mice. Int. J. Nanomedicine 2013, 8, 2409–2419.

Zhang, X. D.; Wu, D.; Shen, X.; Liu, P. X.; Fan, F. Y.; Fan, S. J. In vivo renal clearance, biodistribution, toxicity of gold nanoclusters. Biomaterials 2012, 33, 4628–4638.

Zhang, X. D.; Wu, D.; Shen, X.; Chen, J.; Sun, Y. M.; Liu, P. X.; Liang, X. J. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials 2012, 33, 6408–6419.

De Jong, W. H.; Hagens, W. I.; Krystek, P.; Burger, M. C.; Sips, A. J.; Geertsma, R. E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29, 1912–1919.

Keck, C. M.; Muller, R. H. Nanotoxicological classification system (NCS) - a guide for the risk-benefit assessment of nanoparticulate drug delivery systems. Eur. J. Pharm. Biopharm. 2013, 84, 445–448.

Mussen, F.; Salek, S.; Walker, S. A quantitative approach to benefit-risk assessment of medicines—part 1: The development of a new model using multi-criteria decision analysis; part 2: The practical application of a new model. Pharmacoepidemiol. Drug Saf. 2007, Suppl 1, S42–S46.

Kostarelos, K.; Miller, A. D. Synthetic, self-assembly ABCD nanoparticles: A structural paradigm for viable synthetic non-viral vectors. Chem. Soc. Rev. 2005, 34, 970–994.